PERI-IMPLANTITIS

PERI-IMPLANTITIS was reported 89 times

PERI-IMPLANTITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 INTERLEUKIN-10 2 0.0056
1 CABAZITAXEL 8 0.0023
2 FECAL MICROBIOTA SPORES, LIVE-BRPK 1 0.0008
3 IBANDRONATE SODIUM 2 0.0006
4 RISEDRONATE SODIUM 17 0.0005
5 EDOXABAN TOSYLATE 3 0.0004
6 CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE 1 0.0004
7 ABIRATERONE ACETATE 8 0.0002
8 DENOSUMAB 33 0.0002
9 RAMUCIRUMAB 1 0.0002
10 ENZALUTAMIDE 9 0.0002
11 ZOLEDRONIC ACID 6 0.0001
12 LORLATINIB 1 0.0001
13 LETROZOLE TABLETS 6 0.0001
14 CEFTRIAXONE SODIUM 4 0.0001
15 LETROZOLE 6 0.0001
16 POTASSIUM CHLORIDE ORAL 9 0.0001
17 METRONIDAZOLE TOPICAL 4 0.0001
18 POTASSIUM CHLORIDE 9 0.0001
19 SUNITINIB MALATE 3 0.0001
20 METRONIDAZOLE 4 0.0001
21 LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 3 0.0001
22 DICLOFENAC SODIUM 1% 2 0.0001
23 DICLOFENAC SODIUM TOPICAL GEL, 1% 2 0.0001
24 ALENDRONATE SODIUM TABLET 1 0.0001
25 PALBOCICLIB 5 0.0001
26 LOSARTAN 9 0.0001
27 PREDNISOLONE ORAL SOLUTION 9 0.0000
28 CABOZANTINIB 2 0.0000
29 DESVENLAFAXINE SUCCINATE 1 0.0000
30 ENALAPRIL 2 0.0000
31 METFORMIN ER 500 MG 10 0.0000
32 METOPROLOL TARTRATE 9 0.0000
33 RIBOCICLIB 1 0.0000
34 OSIMERTINIB 1 0.0000
35 EPINEPHRINE 2 0.0000
36 PEMETREXED DISODIUM 1 0.0000
37 ATORVASTATIN CALCIUM 6 0.0000
38 FUROSEMIDE 9 0.0000
39 NIVOLUMAB 2 0.0000
40 LIDICAINE 1 0.0000
41 LIDOCAINE, MENTHOL 1 0.0000
42 ALENDRONATE SODIUM 2 0.0000
43 USTEKINUMAB 2 0.0000
44 LIDOCAINE 4% 1 0.0000
45 ASPIRIN 9 0.0000
46 LIDOCAINE HYDROCHLORIDE 1 0.0000
47 DICLOFENAC SODIUM 2 0.0000
48 PACLITAXEL 1 0.0000
49 LEVOTHYROXINE SODIUM ANHYDROUS 1 0.0000
50 PEMBROLIZUMAB 1 0.0000
51 BEVACIZUMAB 1 0.0000
52 SECUKINUMAB 1 0.0000
53 RITUXIMAB 1 0.0000
54 INFLIXIMAB 1 0.0000
55 PANTOPRAZOLE 1 0.0000
56 AMLODIPINE 1 0.0000
57 DEXAMETHASONE 1.5 MG 1 0.0000
58 DEXAMETHASONE 1 0.0000
59 LEVOTHYROXINE SODIUM 1 0.0000
60 METHOTREXATE SODIUM 1 0.0000